Maintenance Treatment With Low-Dose Decitabine After Allogeneic Hematopoietic Cell Transplantation in Patients With Adult Acute Lymphoblastic Leukemia

BACKGROUND: Post-transplant relapse remains a principal leading cause of failure after allogeneic hematopoietic stem cell transplantation (allo-HSCT) in patients with adult acute lymphoblastic leukemia (ALL). The aim of this study was to investigate the efficacy and safety of low-dose decitabine on...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jia, Jiang, Zhong-Xing, Xie, Xin-Sheng, Wan, Ding-Ming, Cao, Wei-Jie, Wang, Meng, Liu, Zhen-Zhen, Dong, Zhen-Kun, Wang, Hai-Qiong, Lu, Run-Qing, Zhang, Yin-Yin, Cheng, Qian-Qian, Fan, Ji-Xin, Li, Wei, He, Fei, Guo, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415411/
https://www.ncbi.nlm.nih.gov/pubmed/34485147
http://dx.doi.org/10.3389/fonc.2021.710545

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415411/
https://www.ncbi.nlm.nih.gov/pubmed/34485147
http://dx.doi.org/10.3389/fonc.2021.710545

Ejemplares similares